Can I Request an Extension to My ESI Period for an Event That Occurred During a Timeframe That Includes a Previous Extension?

August 3, 2021

Some investigators experience a lapse in their research or research training or experience periods of less than full-time effort during the 10-year ESI period. The NIH considers requests to extend the ESI period for reasons that can include medical concerns, disability, family care, and more. However, the ESI Extension Committee will only consider requests for events that occur within the initial 10 years from receipt of terminal research degree or end of post-graduate clinical training, whichever date is later.

Additional Clarifications to Biosketch and Other Support Policies Now Available

August 2, 2021

Although not required until January 2022, more and more applicants and recipients are following our advice and transitioning now to the updated formats and instructions for biosketch and other support documents. As a result, we’ve received a number of requests for additional clarification to our policies. We’ve updated and added FAQs, posted clarified instructions, and adjusted our other support sample document in response.

Further Demographic Analyses of NIH R01 Grant Outcomes of T32 Postdoctoral Participants

July 27, 2021

Postdoctoral NIH T32 programs aim to provide select trainees with experience to enable successful career and research development. In a previous posting, we presented NIH career development, or K award, and R01 equivalent research grant outcomes of participants in post-doctoral T32 programs. Here we present further analyses focusing on the association of under-represented minority (URM) status with subsequent K or R01 awards.

Data on Implementing NIH’s Next Generation Researchers Initiative

July 12, 2021

Since launching in 2017, NIH’s Next Generation Researchers Initiative (NGRI) is continuing to address longstanding challenges faced by researchers trying to embark upon and sustain independent research careers as well as to promote the stability and diversity of the biomedical research workforce. Today, we are sharing data on our progress towards increased support for ESIs and other targeted groups.